semaglutide binge eating disorder case report Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? GLP-1RAs and Obesity Associated with

The move follows an earlier FDA recommendation to schedule 7-OH because of its opioid properties and potential risks to consumers

Sub-visible particulates (below 50 microns) are not detectable by visual inspection

In the STEP trials for semaglutide and the SURMOUNT trials for tirzepatide, participants achieved substantial weight loss that far exceeded what most people accomplish through diet and exercise alone

When your blood sugar drops quickly, the lens inside your eye can temporarily swell or change shape, making it harder to focus clearly

The amount of weight loss varies among individuals and depends on factors such as diet, exercise, and adherence to the medication regimen

Straus DJ, Andreeff M , Gee T, Koziner B, Mertelsmann R, Hansen H, Chaganti R, McKenzie S, Miller D, Clarkson BD